Foresite Capital is a healthcare organization which has been offering medical care services in the United States. Recently the heath facility announced that it had appointed Molly He as a Venture Partner of the organization. Doctor, He is an experienced medical expert who has an experience of more than 15 years in the medical and health sector. Before joining Foresite Capital, Doctor Molly served at Illumina acting as a Senior Director. Doctor Molly is experienced in pharmacy and genomic research and development. Jim Tananbaum is the Managing Director ND THE Chief executive officer of Foresite Capital, and he was happy to welcome Dr. Molly in the team saying that she will bring her experience and skills which will be of a great benefit.
Doctor Molly is also a leader who a real leadership record. At Illumina, she was responsible for protein reagent modernization as well as its improvement. She has also worked for several other medical facilities including Pacific Bioscience where she served as the head of protein science, and her primary responsibility was the development of protein reagent for the organization’s single molecular real-time sequencing chemistry. Dr. Molly began her career by serving at a pharmaceutical company where she mainly focused on antibodies which target cancer and other immune diseases. Dr. He does not only practice medicine, but she is also an author. She holds a Bachelor’s degree in medicine from Nankai University and a Ph.D. in protein biophysics from the University of California Los Angeles.
Jim Tananbaum is the founder and the President of Foresite Capital. Jim experienced in the medical field as well as other areas of investment. Before the foundation of Foresite Capital, Mr. Tananbaum had also co-founded two other organizations which included healthcare investment practice and biopharmaceutical companies. From the beginning of his career in the medical sector, Jim primary focus has been on planning, operations as well as financial opportunities to see the expansion of the medical care and build the franchise of medical care business.
According to Businesswire, Jim Tananbaum attended Harvard University Medical and Business Schools as well as Massachusetts Institute of Technology. After his graduation, he founded Geltex Pharmaceuticals which was later sold. Mr. Jim can well be described as an investor who has been successful in his investments which include Prospective Ventures, and Sierra Ventures.
Follow him on Twitter: https://twitter.com/foresitecap